Intravesical docetaxel for high-risk non-muscle invasive bladder cancer after Bacillus Calmette-Guerin failure. Shantharam G, Amin A, Pereira J, Kott O, et al. Curr Urol 2021;15:33-38.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Shantharam G, Amin A, Pereira J, Kott O, et al. Intravesical docetaxel for high-risk non-muscle invasive bladder cancer after Bacillus Calmette-Guerin failure. Curr Urol 2021;15:33-38.
PMID: 34084119